Literature DB >> 26793370

Time for science to catch up with clinical practice?

Sara Ariotti1, Giuseppe Gargiulo1, Stephan Windecker1, Marco Valgimigli1.   

Abstract

Year:  2015        PMID： 26793370      PMCID： PMC4703667          DOI： 10.3978/j.issn.2072-1439.2015.12.26

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  20 in total

1.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  J Am Coll Cardiol       Date:  2011-11-07       Impact factor: 24.094

2.  Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY).

Authors:  Marco Valgimigli; Gianluca Campo; Gianfranco Percoco; Monia Monti; Fabrizio Ferrari; Carlo Tumscitz; Andrea Zuffi; Federico Colombo; Moh'd Kubbajeh; Caterina Cavazza; Elisa Cangiano; Matteo Tebaldi; Monica Minarelli; Chiara Arcozzi; Antonella Scalone; Alice Frangione; Marco Borghesi; Jlenia Marchesini; Giovanni Parrinello; Roberto Ferrari
Journal:  Am Heart J       Date:  2010-11       Impact factor: 4.749

Review 3.  Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Suetonia C Palmer; Lucia Di Micco; Mona Razavian; Jonathan C Craig; Vlado Perkovic; Fabio Pellegrini; Massimiliano Copetti; Giusi Graziano; Gianni Tognoni; Meg Jardine; Angela Webster; Antonio Nicolucci; Sophia Zoungas; Giovanni F M Strippoli
Journal:  Ann Intern Med       Date:  2012-03-20       Impact factor: 25.391

4.  Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).

Authors:  Marco Valgimigli; Matteo Tebaldi; Marco Borghesi; Pascal Vranckx; Gianluca Campo; Carlo Tumscitz; Elisa Cangiano; Monica Minarelli; Antonella Scalone; Caterina Cavazza; Jlenia Marchesini; Giovanni Parrinello
Journal:  JACC Cardiovasc Interv       Date:  2013-12-11       Impact factor: 11.195

5.  Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.

Authors:  Philip Urban; Ian T Meredith; Alexandre Abizaid; Stuart J Pocock; Didier Carrié; Christoph Naber; Janusz Lipiecki; Gert Richardt; Andres Iñiguez; Philippe Brunel; Mariano Valdes-Chavarri; Philippe Garot; Suneel Talwar; Jacques Berland; Mohamed Abdellaoui; Franz Eberli; Keith Oldroyd; Robaayah Zambahari; John Gregson; Samantha Greene; Hans-Peter Stoll; Marie-Claude Morice
Journal:  N Engl J Med       Date:  2015-10-14       Impact factor: 91.245

6.  Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey.

Authors:  Marco Valgimigli; Francesco Costa; Robert Byrne; Michael Haude; Andreas Baumbach; Stephan Windecker
Journal:  EuroIntervention       Date:  2015-05       Impact factor: 6.534

7.  6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial.

Authors:  Martine Gilard; Paul Barragan; Arif A L Noryani; Hussam A Noor; Talib Majwal; Thomas Hovasse; Philippe Castellant; Michel Schneeberger; Luc Maillard; Erwan Bressolette; Jaroslaw Wojcik; Nicolas Delarche; Didier Blanchard; Bernard Jouve; Olivier Ormezzano; Franck Paganelli; Gilles Levy; Joël Sainsous; Didier Carrie; Alain Furber; Jacques Berland; Oliver Darremont; Hervé Le Breton; Anne Lyuycx-Bore; Antoine Gommeaux; Claude Cassat; Alain Kermarrec; Pierre Cazaux; Philippe Druelles; Raphael Dauphin; Jean Armengaud; Patrick Dupouy; Didier Champagnac; Patrick Ohlmann; Knut Endresen; Hakim Benamer; Robert Gabor Kiss; Imre Ungi; Jacques Boschat; Marie-Claude Morice
Journal:  J Am Coll Cardiol       Date:  2014-11-16       Impact factor: 24.094

8.  Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease.

Authors:  Omar K Siddiqi; Kyle J Smoot; Alyssa B Dufour; Kelly Cho; Melissa Young; David R Gagnon; Samantha Ly; Sara Temiyasathit; David P Faxon; J Michael Gaziano; Scott Kinlay
Journal:  Heart       Date:  2015-07-24       Impact factor: 5.994

9.  ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.

Authors:  Stefanie Schulz-Schüpke; Robert A Byrne; Jurrien M Ten Berg; Franz-Josef Neumann; Yaling Han; Tom Adriaenssens; Ralph Tölg; Melchior Seyfarth; Michael Maeng; Bernhard Zrenner; Claudius Jacobshagen; Harald Mudra; Eberhard von Hodenberg; Jochen Wöhrle; Dominick J Angiolillo; Barbara von Merzljak; Nonglag Rifatov; Sebastian Kufner; Tanja Morath; Antonia Feuchtenberger; Tareq Ibrahim; Paul W A Janssen; Christian Valina; Yi Li; Walter Desmet; Mohamed Abdel-Wahab; Klaus Tiroch; Christian Hengstenberg; Isabell Bernlochner; Marcus Fischer; Heribert Schunkert; Karl-Ludwig Laugwitz; Albert Schömig; Julinda Mehilli; Adnan Kastrati
Journal:  Eur Heart J       Date:  2015-01-23       Impact factor: 29.983

10.  Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Authors:  Sripal Bangalore; Sunil Kumar; Mario Fusaro; Nicholas Amoroso; Michael J Attubato; Frederick Feit; Deepak L Bhatt; James Slater
Journal:  Circulation       Date:  2012-05-14       Impact factor: 29.690
View more
  1 in total

Review 1.  Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

Authors:  Sara Ariotti; Giuseppe Gargiulo; Marco Valgimigli
Journal:  Curr Cardiol Rep       Date:  2017-01       Impact factor: 2.931
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.